Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_assertion type Assertion NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_head.
- NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_assertion wasGeneratedBy ECO_0000203 NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_provenance.
- NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_assertion wasDerivedFrom befree-20150227 NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_provenance.
- NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_assertion SIO_000772 23264089 NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_provenance.
- NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_assertion evidence source_evidence_literature NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_provenance.
- NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_assertion description "[The risk of endometrial cancer in the entire group of EPCAM deletion carriers is significantly lower than that in MSH2 mutation carriers, but the actual risk appears to be dependent on the size and location of the EPCAM deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542321.RAvQSQ1I8hI-5CPXcE_iShwjkY9AqNZpnnZofZagJOC8s130_provenance.